05/09/2025
4:30 PM | Chromocell Therapeutics (Filer)
| Form PREM14C | |
05/01/2025
4:05 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
5:11 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2025
8:30 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
8:31 PM | Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
4:08 PM | Chromocell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/03/2025
6:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:09 PM | Chromocell Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
4:27 PM | Alexandra Wood Inc. (0002052171) (Filed by)
Chromocell Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/19/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
12/11/2024
3:06 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
Get the Latest News and Ratings for CHRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/02/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
11/22/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
11/21/2024
8:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:03 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:19 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:20 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:22 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
4:14 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:05 PM | 3i, LP (Filed by)
Chromocell Therapeutics (Subject)
| Form SC 13G/A | |
10/24/2024
7:30 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
4:08 PM | Chromocell Therapeutics (Filer)
| Form DEF 14A | |
09/16/2024
3:55 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:56 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:35 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
4:30 PM | Chromocell Therapeutics (Filer)
| Form PRE 14A | |
08/13/2024
4:23 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
3:31 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:50 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
08/06/2024
3:49 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:06 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
8:07 AM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:08 AM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:15 AM | Chromocell Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/02/2024
4:15 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 3/A | |
07/02/2024
4:17 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:05 PM | Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump set to Boost Social Security Checks by 400%? (Ad) If you're collecting or planning to collect social security...
You should see this presentation about President Trump's Executive Order #14196.
Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse...
But BOOST benefits for millions of retirees by up to 400%.
No wonder the financial times called this new initiative... Click here to see the details because the stakes couldn't be any higher. |
06/18/2024
7:06 PM | Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:07 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4/A | |
06/18/2024
7:00 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:01 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:02 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:03 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
